Perchlorate-induced structural diversity in thiosemicarbazone copper(ii) complexes provides insights to understand the reactivity in acidic and basic media

Rubén Gil-García, Gotzon Madariaga, Alondra Jiménez-Pérez, Ignacio Herrán-Torres, Adrián Gago-González, María Ugalde, Vaidas Januskaitis, Joaquín Barrera-García, Maite Insausti, María S. Galletero, Joaquín Borrás, José Vicente Cuevas, Rosa Pedrido, Patricia Gómez-Saiz, Luis Lezama and Javier García-Tojal

CrystEngComm, 2023, 25, 2213
DOI: 10.1039/D3CE00119A

Copper complexes for the promotion of iminopyridine ligands derived from β-alanine and self-aldol additions: relaxivity and cytotoxic properties

Lucía Álvarez-Miguel, Inés Álvarez-Miguel, Jose M. Martín-Álvarez, Celedonio M. Álvarez, Guillaume Rogez, Raúl García-Rodríguez and Daniel Miguel

Dalton Trans., 2019, 48, 17544
DOI: 10.1039/C9DT03822A

Comparative solution study of imidazole-derived thiosemicarbazone complexes: effects of methylation and aromatic conjugation on the redox properties, anticancer, and antibacterial activity

Tatsiana V. Petrasheuskaya, Márton A. Kiss, Peter Rapta, Csenge Fonay, Nóra V. May, Gabriella Spengler, Éva Frank and Éva A. Enyedy

Dalton Trans., 2026, 55, 4269
DOI: 10.1039/D5DT02939B

Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathway

Xiu-Ying Qin, Ya-Nan Wang, Xin-Ping Yang, Juan-Juan Liang, Ji-Lin Liu and Zhao-Hui Luo

Dalton Trans., 2017, 46, 16446
DOI: 10.1039/C7DT03242K

Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias

Daniel L. Sun, Soumya Poddar, Roy D. Pan, Ethan W. Rosser, Evan R. Abt, Juno Van Valkenburgh, Thuc M. Le, Vincent Lok, Selena P. Hernandez, Janet Song, Joanna Li, Aneta Turlik, Xiaohong Chen, Chi-An Cheng, Wei Chen, Christine E. Mona, Andreea D. Stuparu, Laurent Vergnes, Karen Reue, Robert Damoiseaux, Jeffrey I. Zink, Johannes Czernin, Timothy R. Donahue, Kendall N. Houk, Michael E. Jung and Caius G. Radu

RSC Med. Chem., 2020, 11, 392
DOI: 10.1039/C9MD00594C

Reactivity of Cu(ii)–, Zn(ii)– and Fe(ii)–thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation

Alice Santoro, Bertrand Vileno, Òscar Palacios, Manuel David Peris-Díaz, Gilles Riegel, Christian Gaiddon, Artur Krężel and Peter Faller

Metallomics, 2019, 11, 994
DOI: 10.1039/c9mt00061e

Mixed-ligand copper(ii)-diimine complexes of 3-formylchromone-N4-phenyl thiosemicarbazone: 5,6-dmp co-ligand confers enhanced cytotoxicity

Anjaneyulu Mamindla, Dhanashree Murugan, Manikandan Varadhan, Tamilarasan Ajaykamal, Loganathan Rangasamy, Mallayan Palaniandavar and Venugopal Rajendiran

RSC Adv., 2024, 14, 31704
DOI: 10.1039/D4RA04997G

Bifunctional ligand design for modulating mutant p53 aggregation in cancer

Jessica J. Miller, Anaïs Blanchet, Christophe Orvain, Lucienne Nouchikian, Yasmin Reviriot, Ryan M. Clarke, Diego Martelino, Derek Wilson, Christian Gaiddon and Tim Storr

Chem. Sci., 2019, 10, 10802
DOI: 10.1039/C9SC04151F

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex

Ping Yu, Jungang Deng, Jinhua Cai, Zhenlei Zhang, Juzheng Zhang, Muhammad Hamid Khan, Hong Liang and Feng Yang

Metallomics, 2019, 11, 1372
DOI: 10.1039/c9mt00124g

Complex formation and cytotoxicity of Triapine derivatives: a comparative solution study on the effect of the chalcogen atom and NH-methylation

Éva A. Enyedy, Nóra V. May, Veronika F. S. Pape, Petra Heffeter, Gergely Szakács, Bernhard K. Keppler and Christian R. Kowol

Dalton Trans., 2020, 49, 16887
DOI: 10.1039/D0DT03465G

Copper(i) complexes with quinolone appended 1,8-naphthalimide conjugates: structural characterization, DNA and protein binding and cytotoxicity studies

Sabiha A. Shaikh, Satish S. Bhat, Vidyanand K. Revankar, Naveen S., Karthik Kumara, N. K. Lokanath, Ray J. Butcher, Vijay Kumbar and Kishore Bhat

New J. Chem., 2022, 46, 16801
DOI: 10.1039/D2NJ02655D

Pyridoxal hydrochloride thiosemicarbazones with copper ions inhibit cell division via Topo-I and Topo-IIɑ

Jinxu Qi, Yunyun Zheng, Bin Li, Yu Ai, Mengyao Chen and Xinhua Zheng

Journal of Inorganic Biochemistry, 2022, 232, 111816
DOI: 10.1016/j.jinorgbio.2022.111816

Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity

Richa, Vinod Kumar and Ramesh Kataria

Journal of Inorganic Biochemistry, 2024, 251, 112440
DOI: 10.1016/j.jinorgbio.2023.112440

Water soluble glucose derivative of thiocarbohydrazone acts as ionophore with cytotoxic effects on tumor cells

Carmela Bonaccorso, Giulia Grasso, Nicolò Musso, Vincenza Barresi, Daniele F. Condorelli, Diego La Mendola and Enrico Rizzarelli

Journal of Inorganic Biochemistry, 2018, 182, 92
DOI: 10.1016/j.jinorgbio.2018.01.019

Multifunctional Compounds for Activation of the p53‐Y220C Mutant in Cancer

Jessica J. Miller, Christophe Orvain, Shireen Jozi, Ryan M. Clarke, Jason R. Smith, Anaïs Blanchet, Christian Gaiddon, Jeffrey J. Warren and Tim Storr

Chemistry A European J, 2018, 24, 17734
DOI: 10.1002/chem.201802677

A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer

Weibin Lian, Peidong Yang, Liangqiang Li, Debo Chen and Chuan Wang

Front. Med., 2023, 10
DOI: 10.3389/fmed.2023.1194046

Synthesis, characterisation and biological studies of mixed-ligand nickel (II) complexes containing imidazole derivatives and thiosemicarbazide Schiff bases

Nurul N.M. Ishak, Junita Jamsari, A.Z. Ismail, Mohamed I.M. Tahir, Edward R.T. Tiekink, Abhi Veerakumarasivam and Thahira B.S.A. Ravoof

Journal of Molecular Structure, 2019, 1198, 126888
DOI: 10.1016/j.molstruc.2019.126888

CuET promotes cuproptosis and ferroptosis of lung cancer cells by interacting directly with polyunsaturated phospholipids

Jie Zhang, Chengying Lei, Guangzhe Zheng, Bingxue Nie, Yiju Wei, Yanqin Lu and Shuping Zhang

iScience, 2026, 29, 115438
DOI: 10.1016/j.isci.2026.115438

Unravelling the antitumoral potential of novel bis(thiosemicarbazonato) Zn(II) complexes: structural and cellular studies

Elisa Palma, Hugo M. Botelho, Goreti Ribeiro Morais, Inês Rodrigues, Isabel Cordeiro Santos, Maria Paula Cabral Campello, Paula Raposinho, Ana Belchior, Susana Sousa Gomes, Maria Fátima Araújo, Isabel Correia, Nadia Ribeiro, Sofia Gama, Filipa Mendes and António Paulo

J Biol Inorg Chem, 2019, 24, 71
DOI: 10.1007/s00775-018-1629-6

Low Catalytic Redox Activity of α-N-Pyridylthiosemicarbazone Iron Complexes Suggests an Indirect ROS Generation Mechanism in Their Biological Activity

Bharath Vinjamuri, Christian R. Kowol and Peter Faller

Inorg. Chem., 2025, 64, 20340
DOI: 10.1021/acs.inorgchem.5c03520

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment

Dahye Noh, Hokyung Lee, Sangmin Lee, In-Cheol Sun and Hong Yeol Yoon

Biomater Res, 2024, 28
DOI: 10.34133/bmr.0094

Insights into molecular mechanisms of metallodrugs using metallomic studies

Sara La Manna and Daniela Marasco

Inorganica Chimica Acta, 2024, 560, 121816
DOI: 10.1016/j.ica.2023.121816

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma

Like Zhong, Junfeng Zhu, Qi Shu, Gaoqi Xu, Chaoneng He, Luo Fang and Yanqing Liu

Journal of Oncology, 2023, 2023, 1
DOI: 10.1155/2023/5925935

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance

Maria V. Babak and Dohyun Ahn

Biomedicines, 2021, 9, 852
DOI: 10.3390/biomedicines9080852

Thiosemicarbazone Mixed-Valence Cu(I/II) Complex against Lung Adenocarcinoma Cells through Multiple Pathways Involving Cuproptosis

Aili Li, Kai Huang, Weiping Pan, Youru Wu, Yuwei Liang, ZhenLei Zhang, Daqi Wu, Libing Ma and Yi Gou

J. Med. Chem., 2024, 67, 9091
DOI: 10.1021/acs.jmedchem.4c00257

Developing drugs targeting transition metal homeostasis

Claire M. Weekley and Chuan He

Current Opinion in Chemical Biology, 2017, 37, 26
DOI: 10.1016/j.cbpa.2016.12.011

Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology

George J Kontoghiorghes and Christina N Kontoghiorghe

Expert Opinion on Investigational Drugs, 2019, 28, 593
DOI: 10.1080/13543784.2019.1631284

Optimizing Nickel Complex With Thiosemicarbazone for Viral (SARS‐CoV‐2) Applications and Cancer Therapy: Synthesis, DFT Calculations, Molecular Docking, Molecular Dynamics Simulations, and Anticancer Activity

Jebiti Haribabu, Murugesan Panneerselvam, Srividya Swaminathan, Rohith Ramasamy, Rajadurai Vijay Solomon, Daniel Moraga, Varaprasad Kokkarachedu, Luciano T. Costa, Jose A. Pino, Arunachalam Arulraj, Juan F. Santibanez and Nattamai Bhuvanesh

Applied Organom Chemis, 2025, 39
DOI: 10.1002/aoc.70346

Zhe Zhang, Yue Wu, Shengyao Wang, Guanduo Wang, Huanqing Zhang, Xiaojuan Yang, Gangli Liu and Shengyun Huang

Advanced Therapeutics, 2024, 7
DOI: 10.1002/adtp.202300198

Cytotoxic cobalt (III) Schiff base complexes: in vitro anti-proliferative, oxidative stress and gene expression studies in human breast and lung cancer cells

Balakrishnan Gowdhami, Yesaiyan Manojkumar, R. T. V. Vimala, Venkatesan Ramya, Balakrishnan Karthiyayini, Balamuthu Kadalmani and Mohammad Abdulkader Akbarsha

Biometals, 2022, 35, 67
DOI: 10.1007/s10534-021-00351-8

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases

George Kontoghiorghes and Christina Kontoghiorghe

Cells, 2020, 9, 1456
DOI: 10.3390/cells9061456

Binding Models of Copper(II) Thiosemicarbazone Complexes with Human Serum Albumin: A Speciation Study

Nóra V. May, Attila Jancsó and Éva A. Enyedy

Molecules, 2021, 26, 2711
DOI: 10.3390/molecules26092711

Copper(II) complexes with pyridoxal dithiocarbazate and thiosemicarbazone ligands: crystal structure, spectroscopic analysis and cytotoxic activity

Claudia C. Gatto, Marcio A. S. Chagas, Iariane J. Lima, Francyelli Mello Andrade, Hugo D. Silva, Gabrielly R. Abrantes and Elisângela P. S. Lacerda

Transit Met Chem, 2019, 44, 329
DOI: 10.1007/s11243-018-00299-8

Theoretical Studies of Copper(II) Hydroxamate Complexes: Molecular Structures, HOMO–LUMO Study, Reactivity Descriptors, Spectral Analyses, and Molecular Docking Study

Vineet Kumar Choudhary, Parul Chauhan, Kanika Mandhan and Meena Kumari

Russ. J. Inorg. Chem., 2025, 70, 546
DOI: 10.1134/S0036023624603830

A new hybrid ligand and its metal complexes from a natural plant (Styrax officinalis) bearing egonol, thiosemicarbazone and oxime units, and their anti‐cancer activities

Ilknur Babahan‐Bircan, Safiye Emirdağ, Ali Özmen, Mürüvvet Abbak, Oguejiofo T. Ujam, Ilke Demirkaya and M. Emin Günay

Applied Organom Chemis, 2022, 36
DOI: 10.1002/aoc.6784

Structural analysis and biological functionalities of iron(III)– and manganese(III)–thiosemicarbazone complexes: in vitro anti-proliferative activity on human cancer cells, DNA binding and cleavage studies

Büşra Kaya, Zehra Kübra Yılmaz, Onur Şahin, Belma Aslim, Ümmügülsüm Tükenmez and Bahri Ülküseven

J Biol Inorg Chem, 2019, 24, 365
DOI: 10.1007/s00775-019-01653-6

Thiosemicarbazonecopper/Halido Systems: Structure and DFT Analysis of the Magnetic Coupling

Alondra Jiménez-Pérez, Sara Marcos-Gómez, Gotzon Madariaga, Manuel Zapico, Pablo Vitoria, Javier Tercero, M. Begoña Torres, Luis Lezama, José Vicente Cuevas, Iñigo Etxebarria and Javier García-Tojal

Inorganics, 2023, 11, 31
DOI: 10.3390/inorganics11010031

HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model

Yi Gou, Zhenlei Zhang, Dongyang Li, Lei Zhao, Meiling Cai, Zhewen Sun, Yongping Li, Yao Zhang, Hamid Khan, Hongbing Sun, Tao Wang, Hong Liang and Feng Yang

Drug Delivery, 2018, 25, 321
DOI: 10.1080/10717544.2018.1428245

Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit

Elizabeth W. Hunsaker and Katherine J. Franz

Inorg. Chem., 2019, 58, 13528
DOI: 10.1021/acs.inorgchem.9b01029

Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications

Grażyna Gromadzka, Beata Tarnacka, Anna Flaga and Agata Adamczyk

IJMS, 2020, 21, 9259
DOI: 10.3390/ijms21239259

Cuproptosis: Mechanism and Application in Lymphoma

Yubo Wang, Fengyue Yin, Quanyi Jin, Chen Liu, Zhongquan Qi, Dengyue Chen and Yiming Luo

CCDT, 2025, 25, 766
DOI: 10.2174/0115680096296742240614100116

Use of Core-Cross-Linked Polymeric Micelles Induced by the Selective Detection of Cu(II) Ions for the Sustained Release of a Model Drug

Jae Min Bak and Hyung-il Lee

ACS Appl. Mater. Interfaces, 2019, 11, 14368
DOI: 10.1021/acsami.9b02432

Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes

Rukhsana Anjum, Duraippandi Palanimuthu, Danuta S. Kalinowski, William Lewis, Kyung Chan Park, Zaklina Kovacevic, Irfan Ullah Khan and Des R. Richardson

Inorg. Chem., 2019, 58, 13709
DOI: 10.1021/acs.inorgchem.9b01281

The copper(II) complexes of new anthrahydrazone ligands: In vitro and in vivo antitumor activity and structure-activity relationship

Rui-Xue Liu, Chen-Yu Wang, Ying-Shu Wu, Ru-Yi Luo, Xiao-Hong Jiang, Meng-Ting Tang, Yan-Cheng Liu, Zhen-Feng Chen and Hong Liang

Journal of Inorganic Biochemistry, 2020, 212, 111208
DOI: 10.1016/j.jinorgbio.2020.111208

Comparative evaluation of the structure and antitumor mechanism of mononuclear and trinucleated thiosemicarbazone Cu(II) complexes

Yunyun Zheng, Kai Wei, Yingying Gao, Ziyan Zhou, Xinhua Zheng, Jiuling Li and Jinxu Qi

Journal of Inorganic Biochemistry, 2023, 240, 112116
DOI: 10.1016/j.jinorgbio.2022.112116

Metal Drugs and the Anticancer Immune Response

Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler and Walter Berger

Chem. Rev., 2019, 119, 1519
DOI: 10.1021/acs.chemrev.8b00396

Evaluation of dual-function molecules containing both Zn-Ionophore and aggregation inhibition moieties for mutant p53 protein reactivation

Kalvin Kwan, Ashkan Saffari, Lauryn Grcic, Alfredo L. Acosta, Grace Leech, Benjamin Ma, Omar Castro-Sandoval, Christophe Orvain, Georg Mellitzer, Christian Gaiddon and Tim Storr

Journal of Inorganic Biochemistry, 2026, 274, 113088
DOI: 10.1016/j.jinorgbio.2025.113088

In vitro antioxidant, antiinflammatory and in silico molecular docking studies of thiosemicarbazones

G.R. Subhashree, J. Haribabu, S. Saranya, P. Yuvaraj, D. Anantha Krishnan, R. Karvembu and D. Gayathri

Journal of Molecular Structure, 2017, 1145, 160
DOI: 10.1016/j.molstruc.2017.05.054

Designing Anticancer Multitarget Metal Thiosemicarbazone Prodrug Based on the Nature of Binding Sites of Human Serum Albumin Carrier

Feng Yang and Hong Liang

Future Med. Chem., 2018, 10, 1881
DOI: 10.4155/fmc-2018-0175

Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex

Fatemeh Ghorbani Parsa, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, Seyed Abolfazl Hosseini-Yazdi and Majid Mahdavi

J Biol Inorg Chem, 2020, 25, 383
DOI: 10.1007/s00775-020-01769-0

Complex formation of an estrone-salicylaldehyde semicarbazone hybrid with copper(II) and gallium(III): Solution equilibria and biological activity

Éva A. Enyedy, Tatsiana V. Petrasheuskaya, Márton A. Kiss, Debora Wernitznig, Dominik Wenisch, Bernhard K. Keppler, Gabriella Spengler, Nóra V. May, Éva Frank and Orsolya Dömötör

Journal of Inorganic Biochemistry, 2021, 220, 111468
DOI: 10.1016/j.jinorgbio.2021.111468

Copper ionophore enhanced cisplatin efficiency through DLAT-cuprotosis

Jun Tang, Lingling Zhao, Xiujuan Qiu and Qitian Chen

Toxicology and Applied Pharmacology, 2025, 503, 117496
DOI: 10.1016/j.taap.2025.117496

Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance

Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, Nenad Filipović, Óscar López, Iztok Turel and Petra Heffeter

Drug Resistance Updates, 2021, 58, 100778
DOI: 10.1016/j.drup.2021.100778

Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature

Jinlin Zhou, Dehe Chen, Shiguo Zhang, Chunmei Wang and Li Zhang

Front. Genet., 2023, 13
DOI: 10.3389/fgene.2022.1039983

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands

Jungang Deng, Ping Yu, Zhenlei Zhang, Jun Wang, Jinhua Cai, Na Wu, Hongbin Sun, Hong Liang and Feng Yang

European Journal of Medicinal Chemistry, 2018, 158, 442
DOI: 10.1016/j.ejmech.2018.09.020

Synthesis, X-Ray Crystallographic and Spectroscopic Studies of 2-Benzoylthiopheneketone Thiophene-2-Carboxylic Acid Hydrazone (Bttcah)

Kirk Wilson, Kerrie-Ann Wilson, Mark A. W. Lawrence, Colin D. McMillen, Elizabeth Tonsel-White and Alvin A. Holder

J Chem Crystallogr, 2026, 56
DOI: 10.1007/s10870-026-01086-5

Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights

K.M. Abdullah, Jyoti B. Kaushal, Simran Takkar, Gunjan Sharma, Zahraa W. Alsafwani, Ramesh Pothuraju, Surinder Kumar Batra and Jawed Akhtar Siddiqui

Heliyon, 2024, 10, e27496
DOI: 10.1016/j.heliyon.2024.e27496

Synthesis, thermal behaviour and some properties of CuII complexes with N,O-donor Schiff bases

Agata Bartyzel

J Therm Anal Calorim, 2018, 131, 1221
DOI: 10.1007/s10973-017-6563-2

Solution equilibrium, structural and cytotoxicity studies on Ru(η6-p-cymene) and copper complexes of pyrazolyl thiosemicarbazones

Orsolya Dömötör, Márton A. Kiss, G. Tamás Gál, Nóra V. May, Gabriella Spengler, Márta Nové, Ana Čipak Gašparović, Éva Frank and Éva A. Enyedy

Journal of Inorganic Biochemistry, 2020, 202, 110883
DOI: 10.1016/j.jinorgbio.2019.110883

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Yumin Wang, Yongming Chen, Junjing Zhang, Yihui Yang, Joshua S. Fleishman, Yan Wang, Jinhua Wang, Jichao Chen, Yuanfang Li and Hongquan Wang

Drug Resistance Updates, 2024, 72, 101018
DOI: 10.1016/j.drup.2023.101018

Synthesis, characterization, molecular modeling, and antimicrobial study of copper(II) 2-chlorophenylacetohydroxamate

Vineet Kumar Choudhary, Parul Chauhan, Vandna Sharma, Meena Kumari and Maridula Thakur

Journal of Coordination Chemistry, 2024, 77, 2205
DOI: 10.1080/00958972.2024.2416561

Cytotoxicity of copper(I) complexes containing indole‐based thiosemicarbazones and triphenylphosphine

Periyanayagam Arockia Doss, Jebiti Haribabu, Nithya Balakrishnan, Srividya Swaminathan, Jose A. Pino, Nattamai Bhuvanesh and Ramasamy Karvembu

ChemistrySelect, 2023, 8
DOI: 10.1002/slct.202301277

Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis

Xiaojun Wang, Minghui Zhu, Shanhe Li, Gang Xu, Zhenlei Zhang and Feng Yang

Journal of Inorganic Biochemistry, 2024, 250, 112403
DOI: 10.1016/j.jinorgbio.2023.112403

Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment

Leyla Fouani, Zaklina Kovacevic and Des R. Richardson

Antioxidants & Redox Signaling, 2019, 30, 1096
DOI: 10.1089/ars.2017.7387

ONO‐Pincer‐Type Coumarin‐Based Copper(II) Metalates: Effect on Alzheimer's Disease Pathologies in Caenorhabditis elegans

Giriraj Kalaiarasi, Amirthalingam Mohankumar, Sivadasan Dharani, Frederic Dallemer, Palanisamy Sundararaj and Rathinasabapathi Prabhakaran

Eur J Inorg Chem, 2021, 2021, 1383
DOI: 10.1002/ejic.202100039

Electro‐synthesis approach for some metal ion complexes derived from thiosemicarbazide; characterization, conformational, inhibitory simulation and Hirshfeld surface properties

Moamen S. Refat, Ismail Althagafi, Nashwa El‐Metwaly, Reem Shah, Hanadi Katouah, Ragab R. Amin, Yamany B. Yamany, Tariq Altalhi and Jehan Y. Al‐Humaidi

Applied Organom Chemis, 2020, 34
DOI: 10.1002/aoc.5766

Anticancer Activity and Mode of Action of Copper(II)‐Bis(thiosemicarbazonato) Complexes with Pendant Nitrogen Heterocycles

Elisa Palma, Paula Raposinho, Maria Paula Cabral Campello, Dulce Belo, Joana F. Guerreiro, Vítor Alves, Alexandra Fonseca, Antero J. Abrunhosa, António Paulo and Filipa Mendes

Eur J Inorg Chem, 2021, 2021, 1337
DOI: 10.1002/ejic.202100168

Recent Progress on Chan-Lam Coupling Reactions Catalyzed by Copper(II) Complexes

Xuefeng Jia and Xiangjuan Tong

Chinese Journal of Organic Chemistry, 2022, 42, 2640
DOI: 10.6023/cjoc202203034

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin

Zhenlei Zhang, Juzheng Zhang, Tongfu Yang, Shanhe Li, Gang Xu, Hong Liang and Feng Yang

J. Med. Chem., 2023, 66, 5669
DOI: 10.1021/acs.jmedchem.3c00001

Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer

Shengnan Sha, Luyi Si, Xinrui Wu, Yuanbiao Chen, Hui Xiong, Ying Xu, Wangrui Liu, Haijun Mei, Tao Wang and Mei Li

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.922780

Iron(III) complexes based on tetradentate thiosemicarbazones: Synthesis, characterization, radical scavenging activity andin vitrocytotoxicity on K562, P3HR1 and JURKAT cells

Ferdane Danışman Kalındemirtaş, Büşra Kaya, Mustafa Bener, Onur Şahin, Serap Erdem Kuruca, Tülay Bal Demirci and Bahri Ülküseven

Applied Organom Chemis, 2021, 35
DOI: 10.1002/aoc.6157

Research Progress of Endoplasmic Reticulum Targeting Metal Complexes in Cancer Therapy

Shihang Xu, Xiaoling Wu, Jia Zhu, Qiuming Wu, Lijuan Gao, Feng Yang and Zhenlei Zhang

Drug Development Research, 2024, 85
DOI: 10.1002/ddr.70027

Synthesis, crystal structure, biological evaluation and DNA binding of three Cu(II) complexes as potential anticancer agents

Kehua Wang, Ling Wang, Hongmei Li, Xingzhi Yang, Zhuye Shang, Qian Han, Xiaochun Wang, Qingtao Meng and Mingchang Zhu

Journal of Molecular Structure, 2025, 1327, 141184
DOI: 10.1016/j.molstruc.2024.141184

Differential Reactivity of Metal Binding Domains of Copper ATPases towards Cisplatin and Colocalization of Copper and Platinum

Tiantian Fang, Yao Tian, Siming Yuan, Yaping Sheng, Fabio Arnesano, Giovanni Natile and Yangzhong Liu

Chemistry A European J, 2018, 24, 8999
DOI: 10.1002/chem.201801894

Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients

George J. Kontoghiorghes

IJMS, 2022, 23, 1364
DOI: 10.3390/ijms23031364

Biochemical pathways of copper complexes: progress over the past 5 years

Siffeen Zehra, Sartaj Tabassum and Farukh Arjmand

Drug Discovery Today, 2021, 26, 1086
DOI: 10.1016/j.drudis.2021.01.015

Copper homeostasis: Emerging target for cancer treatment

Yueqin Li

IUBMB Life, 2020, 72, 1900
DOI: 10.1002/iub.2341

Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition Activity

Iryna Stepanenko, Maria V. Babak, Gabriella Spengler, Marta Hammerstad, Ana Popovic-Bijelic, Sergiu Shova, Gabriel E. Büchel, Denisa Darvasiova, Peter Rapta and Vladimir B. Arion

Biomolecules, 2021, 11, 862
DOI: 10.3390/biom11060862

Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action

Sebastiano Masuri, Petr Vaňhara, Maria Grazia Cabiddu, Lukáš Moráň, Josef Havel, Enzo Cadoni and Tiziana Pivetta

Molecules, 2021, 27, 49
DOI: 10.3390/molecules27010049

Copper-Induced Tumor Cell Death Mechanisms and Antitumor Theragnostic Applications of Copper Complexes

Yicheng Jiang, Zhiyi Huo, Xiaole Qi, Tongmei Zuo and Zhenghong Wu

Nanomedicine (Lond.), 2022, 17, 303
DOI: 10.2217/nnm-2021-0374

Iron(II) and cobalt(II) Complexes of 3,4‐Dihydroxybenzaldehyde‐4‐ethylthiosemicarbazone: Synthesis, Spectral Studies and Molecular Docking

Safa Faris Kayed

ChemistrySelect, 2023, 8
DOI: 10.1002/slct.202300953

Theoretical Studies of Copper(II) Hydroxamates: Structural, HOMO–LUMO, NBO Analysis and Docking Study Against SARS-CoV-2

Parul Chauhan, Deepika Sharma and Vineet Kumar Choudhary

Russ J Gen Chem, 2025, 95, 2507
DOI: 10.1134/S1070363225602042

Electrocatalytic Oxidation of Hydrazine Using a Cobalt Bis(thiosemicarbazone) Complex

Thamaraichelvan Marichelvam, Ganapathi Murugan, Harish Holla, Venkata Narayanan Naranammalpuram Sundaram and Duraippandi Palanimuthu

Top Catal, 2025, 68, 1257
DOI: 10.1007/s11244-022-01584-8

Molecular structure, UV–Visible spectra and other molecular properties of (E)-2-(2-hydroxy-5-methoxybenzylidene)hydrazinecarbothioamide and its n-methyl variant by using DFT methods

K. Srishailam, L. Ravindranath, Gaddam. Ramesh, D. Praveena, Sunil kumar V, Danikonda.Suresh Kumar, S. Muthu and G.Ramana Rao

Results in Chemistry, 2025, 13, 102026
DOI: 10.1016/j.rechem.2025.102026

Mechanisms of cuproptosis and its relevance to distinct diseases

Qiao-mei Lou, Fei-fan Lai, Jing-wei Li, Kun-jun Mao, Hai-tong Wan and Yu He

Apoptosis, 2024, 29, 981
DOI: 10.1007/s10495-024-01983-0

Synthesis, Structure, and Cytotoxicity of Pd(II) and Cu(II) Complexes with 1-Terpenyl-3-Thiosemicarbazides of Pinane and para-Menthane Series

T. E. Kokina, V. Yu. Komarov, L. A. Glinskaya, S. N. Bizyaev, L. A. Sheludyakova, Yu. A. Eremina, L. S. Klyushova and A. V. Tkachev

J Struct Chem, 2020, 61, 44
DOI: 10.1134/S0022476620010059

Insight into the Anticancer Activity of Copper(II) 5-Methylenetrimethylammonium-Thiosemicarbazonates and Their Interaction with Organic Cation Transporters

Miljan N. M. Milunović, Oleg Palamarciuc, Angela Sirbu, Sergiu Shova, Dan Dumitrescu, Dana Dvoranová, Peter Rapta, Tatsiana V. Petrasheuskaya, Eva A. Enyedy, Gabriella Spengler, Marija Ilic, Harald H. Sitte, Gert Lubec and Vladimir B. Arion

Biomolecules, 2020, 10, 1213
DOI: 10.3390/biom10091213

Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C

Jessica J. Miller, Kalvin Kwan, Anaïs Blanchet, Christophe Orvain, Georg Mellitzer, Jason Smith, Cristina Lento, Lucienne Nouchikian, Sabrina Omoregbee-Leichnitz, Marie Sabatou, Derek Wilson, Christian Gaiddon and Tim Storr

Journal of Inorganic Biochemistry, 2023, 242, 112164
DOI: 10.1016/j.jinorgbio.2023.112164

High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay

Dorothea M. Heuberger, Petra Wolint, Jae-Hwi Jang, Saria Itani, Wolfgang Jungraithmayr, Conny F. Waschkies, Gabriella Meier-Bürgisser, Stefano Andreoli, Katharina Spanaus, Reto A. Schuepbach, Maurizio Calcagni, Christoph J. Fahrni and Johanna Buschmann

Cancers, 2022, 14, 5122
DOI: 10.3390/cancers14205122

The radioenhancement potential of Schiff base derived copper (II) compounds against lung carcinoma in vitro

Gohar Tsakanova, Ani Stepanyan, Elina Arakelova, Violetta Ayvazyan, Vahan Tonoyan, Arsen Arakelyan, Guido Hildebrandt, Elisabeth Schültke and Mounir Tilaoui

PLoS ONE, 2021, 16, e0253553
DOI: 10.1371/journal.pone.0253553

Copper metabolism in cell death and autophagy

Qian Xue, Rui Kang, Daniel J. Klionsky, Daolin Tang, Jinbao Liu and Xin Chen

Autophagy, 2023, 19, 2175
DOI: 10.1080/15548627.2023.2200554

Copper(II) Thiosemicarbazone Complexes and Their Proligands upon UVA Irradiation: An EPR and Spectrophotometric Steady-State Study

Michal Hricovíni, Milan Mazúr, Angela Sîrbu, Oleg Palamarciuc, Vladimir Arion and Vlasta Brezová

Molecules, 2018, 23, 721
DOI: 10.3390/molecules23040721

Iron(III) and nickel(II) complexes of tetradentate thiosemicarbazones: Synthesis, structure, cytotoxicity, and lipophilicity

Mediha Süleymanoğlu, Büşra Kaya, Serap Erdem‐Kuruca and Bahri Ülküseven

J Biochem & Molecular Tox, 2019, 33
DOI: 10.1002/jbt.22383

Synthesis, spectral characterization and X-ray crystallographic study of new copper(I) complexes. Antitumor activity in colon cancer

Noelia González-Ballesteros, David Pérez-Álvarez, M. Carmen Rodríguez-Argüelles, Marta S.C. Henriques, José A. Paixão and Sonia Prado-López

Polyhedron, 2016, 119, 112
DOI: 10.1016/j.poly.2016.08.023

Targeting of the intracellular redox balance by metal complexes towards anticancer therapy

María Isabel Murillo, Christian Gaiddon and Ronan Le Lagadec

Front. Chem., 2022, 10
DOI: 10.3389/fchem.2022.967337

Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes

Bo Zhao, Wei Wu, Liang Liang, Xiaoyong Cai, Yongjun Chen and Weizhong Tang

Heliyon, 2023, 9, e19035
DOI: 10.1016/j.heliyon.2023.e19035

An Iron(III)-S-methylthiosemicarbazone Complex: Synthesis, Spectral Characterization, and Antioxidant Potency Measured by CUPRAC and DPPH Methods

Büşra KAYA

Journal of the Turkish Chemical Society Section A: Chemistry, 2022, 9, 867
DOI: 10.18596/jotcsa.1058398

Probing Vasoreactivity and Hypoxic Phenotype in Different Tumor Grafts Grown on the Chorioallantoic Membrane of the Chicken Embryo In Ovo Using MRI

Johanna Buschmann, Dorothea M. Heuberger, Fatma Kivrak Pfiffner, Petra Wolint, Jae-Hwi Jang, Wolfgang Jungraithmayr, Pietro Giovanoli, Maurizio Calcagni and Conny F. Waschkies

Cancers, 2022, 14, 3114
DOI: 10.3390/cancers14133114

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy

Kavita Gaur, Alexandra M. Vázquez-Salgado, Geraldo Duran-Camacho, Irivette Dominguez-Martinez, Josué A. Benjamín-Rivera, Lauren Fernández-Vega, Lesly Carmona Sarabia, Angelys Cruz García, Felipe Pérez-Deliz, José A. Méndez Román, Melissa Vega-Cartagena, Sergio A. Loza-Rosas, Xaymara Rodriguez Acevedo and Arthur D. Tinoco

Inorganics, 2018, 6, 126
DOI: 10.3390/inorganics6040126

Copper(ii) Complexes Based on 2,2’-Bipyridine and 1,10-Phenanthroline as Potential Objects for Developing Antitumor Drugs

Yu. A. Golubeva and E. V. Lider

J Struct Chem, 2024, 65, 1159
DOI: 10.1134/S0022476624060088

The coordination modes of (thio)semicarbazone copper(II) complexes strongly modulate the solution chemical properties and mechanism of anticancer activity

Vivien Pósa, Bálint Hajdu, Gábor Tóth, Orsolya Dömötör, Christian R. Kowol, Bernhard K. Keppler, Gabriella Spengler, Béla Gyurcsik and Éva A. Enyedy

Journal of Inorganic Biochemistry, 2022, 231, 111786
DOI: 10.1016/j.jinorgbio.2022.111786

Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux

Julia H. Bormio Nunes, Sonja Hager, Marlene Mathuber, Vivien Pósa, Alexander Roller, Éva A. Enyedy, Alessia Stefanelli, Walter Berger, Bernhard K. Keppler, Petra Heffeter and Christian R. Kowol

J. Med. Chem., 2020, 63, 13719
DOI: 10.1021/acs.jmedchem.0c01277

Thiosemicarbazide-based iron(III) and manganese(III) complexes. Structural, electrochemical characterization and antioxidant activity

Büşra Kaya, Kerem Kaya, Atıf Koca and Bahri Ülküseven

Polyhedron, 2019, 173, 114130
DOI: 10.1016/j.poly.2019.114130

Progress in the research of cuproptosis and possible targets for cancer therapy

Jiang Wang, Lan-Zhu Luo, Dao-Miao Liang, Chao Guo, Zhi-Hong Huang, Guo-Ying Sun and Jie Wen

World J Clin Oncol, 2023, 14, 324
DOI: 10.5306/wjco.v14.i9.324

The combination of disulfiram and copper for cancer treatment

Hong Li, Jingyu Wang, Chunfu Wu, Lihui Wang, Zhe-Sheng Chen and Wei Cui

Drug Discovery Today, 2020, 25, 1099
DOI: 10.1016/j.drudis.2020.04.003

Crystal structure and magnetic interactions of a new alkoxido and azido bridged 1D copper(II) coordination polymer

Rahman Bikas, Maria Korabik, Joaquín Sanchiz, Nader Noshiranzadeh, Prinaz Mirzakhani, Amanda Gałkowska, Daria Szeliga and Anna Kozakiewicz-Piekarz

Journal of Solid State Chemistry, 2021, 303, 122484
DOI: 10.1016/j.jssc.2021.122484

Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells

Kateryna Ohui, Iryna Stepanenko, Iuliana Besleaga, Maria V. Babak, Radu Stafi, Denisa Darvasiova, Gerald Giester, Vivien Pósa, Eva A. Enyedy, Daniel Vegh, Peter Rapta, Wee Han Ang, Ana Popović-Bijelić and Vladimir B. Arion

Biomolecules, 2020, 10, 1336
DOI: 10.3390/biom10091336

Estrone–salicylaldehyde N-methylated thiosemicarbazone hybrids and their copper complexes: solution structure, stability and anticancer activity in tumour spheroids

Tatsiana V. Petrasheuskaya, Debora Wernitznig, Márton A. Kiss, Nóra V. May, Dominik Wenisch, Bernhard K. Keppler, Éva Frank and Éva A. Enyedy

J Biol Inorg Chem, 2021, 26, 775
DOI: 10.1007/s00775-021-01891-7

Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

Rayan S. Moussa, Kyung Chan Park, Zaklina Kovacevic and Des R. Richardson

Free Radical Biology and Medicine, 2019, 133, 276
DOI: 10.1016/j.freeradbiomed.2018.03.027

Expression of Cuproptosis-Related Genes in Cancer and Treatment

子晴张

ACM, 2023, 13, 8034
DOI: 10.12677/ACM.2023.1351125

Identification of a cuproptosis-related lncRNA prognostic signature in lung adenocarcinoma

Ran Chen, Haichao Luo, Qitian Chen and Changying Wang

Clin Transl Oncol, 2023, 25, 1617
DOI: 10.1007/s12094-022-03057-6

Exposure to Trace Elements and Risk of Skin Cancer: A Systematic Review of Epidemiologic Studies

Natalie H. Matthews, Katherine Fitch, Wen-Qing Li, J. Steven Morris, David C. Christiani, Abrar A. Qureshi and Eunyoung Cho

Cancer Epidemiology, Biomarkers & Prevention, 2019, 28, 3
DOI: 10.1158/1055-9965.EPI-18-0286

Regulatory roles of copper metabolism and cuproptosis in human cancers

Zhe Wang, Dekui Jin, Shuaishuai Zhou, Niujing Dong, Yuting Ji, Peng An, Jiaping Wang, Yongting Luo and Junjie Luo

Front. Oncol., 2023, 13
DOI: 10.3389/fonc.2023.1123420

Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin

Jun Wang, Yi Gou, Zhenlei Zhang, Ping Yu, Jinxu Qi, Qipin Qin, Hongbin Sun, Xiaoyang Wu, Hong Liang and Feng Yang

Mol. Pharmaceutics, 2018, 15, 2180
DOI: 10.1021/acs.molpharmaceut.8b00045

Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation

Kalvin Kwan, Omar Castro-Sandoval, Benjamin Ma, Diego Martelino, Ashkan Saffari, Xi Lan Liu, Christophe Orvain, Georg Mellitzer, Christian Gaiddon and Tim Storr

Journal of Inorganic Biochemistry, 2024, 251, 112433
DOI: 10.1016/j.jinorgbio.2023.112433

Synthesis, structure, and cytotoxicity of complexes of zinc(II), palladium(II), and copper(I) chlorides with (−)-camphor thiosemicarbazone

Tatyana E. Kokina, Ludmila A. Glinskaya, Liliya A. Sheludyakova, Yuliya A. Eremina, Lubov S. Klyushova, Vladislav Yu. Komarov, Dmitriy A. Piryazev, Alexey V. Tkachev and Stanislav V. Larionov

Polyhedron, 2019, 163, 121
DOI: 10.1016/j.poly.2019.02.020